We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Fields »
 

Field

Term
Gene name

Class

Subclass

Chromosome

External id

In atlas

Reliability

Reliability

Reliability

Validation

Method

Validation

Method

Validation

Method

Validation

Location

Searches

Tissue

Cell type

Expression

Tissue

Specificity

Cell line

Specificity

Cancer

Specificity

Tissue

Detectable

Cell line

Detectable

Cancer

Detectable

Cancer

Prognosis

Category

Score

Score

Score

Antibodies

Column

 
 
ABOUT
HELP
BLOG
  • THE HUMAN PROTEOME
  • THE HUMAN TISSUES
  • THE HUMAN CELL
  • HUMAN PATHOLOGY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
    • NEWS
    • BLOG
    • EVENTS
    • PRESS ROOM
    • LEARN
    • DICTIONARY
    • METHODS
    • CELL LINES
  • THE PROJECT
  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS
  • PUBLICATION DATA
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • LINKS
  • CONTACT
  • TECHNICAL DATA
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • DOWNLOADABLE DATA
  • HELP & FAQ
  • LICENCE & CITATION
  • PRIVACY STATEMENT
  • RELEASE HISTORY
PSMB3
  • premium

    TISSUE

  • CELL

  • PATHOLOGY

PATHOLOGY ATLAS GLIOMA

GENE/PROTEIN

Antibody validation

Dictionary

Glioma

GLIOMA - Survival analysisi

Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival, using best separation (to the left) and median separation (to the right). Patients were divided based on level of expression into one of the two groups "low" or "high". Below each Kaplan-Meier plot, corresponding expression cutoff, 5-year survival for patients with high expression, 5-year survival for patients with low expression and log-rank P value are displayed. For melanoma and glioma, 3-year survival is shown. The survival analysis is described in Assays & Annotation.

The tabs at the top of the survival analysis section can be used to switch between the different cancer subtypes.

Best separation

Median separation

Expression cutoffi

5-year survival for patients with higher expression than the expression cutoff.

76.9 FPKM 94.4 FPKM

3-year survival highi

5-year survival for patients with higher expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

6% 5%

3-year survival lowi

5-year survival for patients with lower expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

9% 8%

Log-rank P valuei

Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.

6.02e-2 6.07e-1

Interactive survival scatter plot (individual patient data)i

The Scatter Survival plot shows the clinical status for all individuals in the patient cohort, based on the same data as in the Kaplan-Meier plots. Living patients are shown in blue and deceased patients in red. The x-axis shows the expression levels (FPKM) of the investigated gene at the time of diagnosis and the y-axis shows the number of years of survival (living years) after the diagnosis.

Individual patient data is displayed in an interactive plot and can be filtered by clicking on one or several category buttons to the left. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be changed to "x linear" by clicking on the "x log" button on the left. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.




Stage:

TCGA RNA samplesi

RNA-seq data is reported as median FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .

Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.

Average FPKM

103.4

Number of samples

153

Samples

Sample

Description

FPKM

TCGA-06-0178-01A 39 years, male, white 385.8
TCGA-27-1831-01A 66 years, male, white 287.2
TCGA-06-0219-01A 67 years, male, white 262.3
TCGA-27-2524-01A 56 years, male, white 220.0
TCGA-12-5295-01A 60 years, female, white 219.2
TCGA-14-1829-01A 57 years, male, black or african american 207.1
TCGA-14-0817-01A 69 years, female, white 200.8
TCGA-12-0616-01A 36 years, female, white 192.9
TCGA-12-3652-01A 60 years, male, white 183.1
TCGA-06-0745-01A 59 years, male, white 179.7
TCGA-28-5213-01A 72 years, male, white 169.2
TCGA-06-5416-01A 23 years, female, white 167.2
TCGA-12-3650-01A 46 years, male, white 154.6
TCGA-27-2526-01A 79 years, female, white 151.1
TCGA-12-1597-01B 62 years, female, white 146.7
TCGA-06-0138-01A 43 years, male, white 146.1
TCGA-28-5220-01A 67 years, male, white 145.0
TCGA-06-0139-01A 40 years, male, white 142.2
TCGA-32-5222-01A 66 years, male, white 139.9
TCGA-41-2572-01A 67 years, male, white 139.0
TCGA-06-0238-01A 46 years, male, white 136.4
TCGA-06-5413-01A 67 years, male, white 136.0
TCGA-27-2521-01A 34 years, male, white 128.5
TCGA-06-0750-01A 43 years, male, white 128.2
TCGA-27-2519-01A 48 years, male, white 128.1
TCGA-27-1832-01A 59 years, female, white 126.7
TCGA-19-2629-01A 60 years, male, white 125.8
TCGA-14-0787-01A 69 years, male, asian 124.9
TCGA-02-2483-01A 43 years, male, asian 124.0
TCGA-06-0744-01A 67 years, male, white 122.9
TCGA-06-5418-01A 75 years, female, white 122.8
TCGA-26-5132-01A 74 years, male, white 120.8
TCGA-06-5411-01A 51 years, male, white 118.9
TCGA-27-1835-01A 53 years, female, white 118.4
TCGA-06-0749-01A 50 years, male, black or african american 118.0
TCGA-26-5133-01A 59 years, male, white 116.5
TCGA-12-0821-01A 62 years, male, white 116.4
TCGA-12-5299-01A 56 years, female, white 116.3
TCGA-26-5136-01B 78 years, female, white 116.0
TCGA-28-5208-01A 52 years, male, white 114.8
TCGA-02-2486-01A 64 years, male, white 114.3
TCGA-32-4213-01A 47 years, female, white 114.0
TCGA-27-2523-01A 63 years, male, white 112.5
TCGA-14-1825-01A 70 years, male, white 112.4
TCGA-41-2571-01A 89 years, male, white 110.7
TCGA-32-1982-01A 76 years, female, white 109.6
TCGA-06-5856-01A 58 years, male, white 108.8
TCGA-26-5134-01A 74 years, male, white 108.3
TCGA-76-4928-01B 85 years, female, white 108.1
TCGA-02-0055-01A 62 years, female, white 107.8
TCGA-06-0211-01B 47 years, male, white 107.2
TCGA-06-0686-01A 53 years, male, white 107.2
TCGA-14-2554-01A 52 years, female, white 106.6
TCGA-06-0156-01A 57 years, male, white 106.0
TCGA-28-5204-01A 72 years, male, white 105.3
TCGA-15-0742-01A 65 years, male, white 105.0
TCGA-06-0743-01A 69 years, male, white 104.2
TCGA-14-1823-01A 58 years, female, white 102.3
TCGA-06-5414-01A 61 years, male, white 101.9
TCGA-76-4932-01A 50 years, female, white 101.6
TCGA-26-5135-01A 72 years, female, white 101.3
TCGA-06-0168-01A 59 years, female, white 100.5
TCGA-06-5412-01A 78 years, female, white 99.9
TCGA-06-5859-01A 63 years, male, white 99.8
TCGA-06-2558-01A 75 years, female, white 99.7
TCGA-02-2485-01A 53 years, male, black or african american 98.8
TCGA-06-0649-01B 73 years, female, black or african american 98.4
TCGA-76-4927-01A 58 years, male, white 97.8
TCGA-06-0644-01A 71 years, male, black or african american 97.7
TCGA-06-5408-01A 54 years, female, white 97.5
TCGA-28-2499-01A 59 years, male, white 97.3
TCGA-06-5410-01A 72 years, female, white 96.5
TCGA-14-0790-01B 64 years, female, white 96.0
TCGA-28-1747-01C 44 years, male, white 95.4
TCGA-76-4925-01A 76 years, male, white 95.3
TCGA-28-5216-01A 52 years, male, white 95.1
TCGA-27-2528-01A 62 years, male, white 94.4
TCGA-06-0646-01A 61 years, male, white 94.2
TCGA-06-2567-01A 65 years, male, white 94.1
TCGA-06-0174-01A 54 years, male, white 93.7
TCGA-06-0645-01A 56 years, female, white 92.5
TCGA-06-2563-01A 72 years, female, white 92.4
TCGA-32-2632-01A 80 years, male, white 92.2
TCGA-41-3915-01A 48 years, male, white 91.7
TCGA-19-2625-01A 76 years, female, white 90.7
TCGA-76-4929-01A 76 years, female, white 90.5
TCGA-06-2569-01A 24 years, female, black or african american 90.4
TCGA-19-4065-01A 36 years, male, white 89.4
TCGA-28-2513-01A 69 years, female, white 88.3
TCGA-19-2624-01A 51 years, male, white 87.5
TCGA-32-2616-01A 48 years, female, white 87.5
TCGA-28-5218-01A 63 years, male, white 87.5
TCGA-06-5417-01A 45 years, female, white 86.9
TCGA-19-1787-01B 49 years, male, white 86.3
TCGA-32-2634-01A 82 years, male, white 86.3
TCGA-76-4931-01A 70 years, female, white 86.2
TCGA-06-0184-01A 63 years, male, white 86.0
TCGA-12-3653-01A 34 years, female, white 85.9
TCGA-06-0132-01A 49 years, male, white 84.0
TCGA-28-2509-01A 77 years, female, white 83.7
TCGA-27-1837-01A 36 years, male, white 83.5
TCGA-28-5207-01A 71 years, male, white 82.6
TCGA-06-2557-01A 76 years, male, black or african american 81.6
TCGA-06-2562-01A 81 years, male, white 81.4
TCGA-16-0846-01A 85 years, male, white 81.0
TCGA-12-0618-01A 49 years, male, white 80.8
TCGA-06-2559-01A 83 years, male, white 80.0
TCGA-28-5209-01A 66 years, female, white 79.7
TCGA-41-5651-01A 59 years, female, black or african american 79.6
TCGA-28-5215-01A 62 years, female, white 77.8
TCGA-14-0781-01B 49 years, male, black or african american 77.3
TCGA-06-1804-01A 81 years, female, white 77.1
TCGA-06-2570-01A 21 years, female, white 76.8
TCGA-06-0157-01A 63 years, female, white 76.8
TCGA-32-2638-01A 67 years, male, white 76.6
TCGA-32-2615-01A 62 years, male, white 76.3
TCGA-06-0187-01A 69 years, male, white 75.5
TCGA-06-0141-01A 62 years, male, white 75.3
TCGA-06-0130-01A 54 years, male, white 74.4
TCGA-14-1034-01A 60 years, female 74.2
TCGA-28-1753-01A 53 years, male, white 73.8
TCGA-08-0386-01A 74 years, male, white 73.4
TCGA-06-0747-01A 53 years, male, white 72.4
TCGA-06-0210-01A 72 years, female, white 72.1
TCGA-26-5139-01A 65 years, female, white 72.1
TCGA-32-1970-01A 59 years, male, white 71.5
TCGA-06-0129-01A 30 years, male, asian 70.7
TCGA-28-2514-01A 45 years, male, asian 70.0
TCGA-32-1980-01A 72 years, male, white 70.0
TCGA-76-4926-01B 68 years, male, white 69.5
TCGA-06-2565-01A 59 years, male, asian 69.4
TCGA-14-0871-01A 75 years, female, white 68.6
TCGA-06-0190-01A 62 years, male, white 67.4
TCGA-06-0158-01A 73 years, male, white 67.2
TCGA-06-2561-01A 53 years, female, white 66.5
TCGA-19-1390-01A 63 years, female, white 64.3
TCGA-19-2620-01A 70 years, male, white 64.1
TCGA-27-1830-01A 57 years, male, white 63.5
TCGA-06-2564-01A 50 years, male, white 62.9
TCGA-27-1834-01A 56 years, male, white 61.6
TCGA-06-5858-01A 45 years, female, white 60.9
TCGA-19-2619-01A 55 years, female, black or african american 60.8
TCGA-19-5960-01A 56 years, male, white 60.8
TCGA-15-1444-01A 21 years, male, white 60.1
TCGA-26-1442-01A 43 years, male, white 58.8
TCGA-06-0125-01A 63 years, female, white 58.8
TCGA-16-1045-01B 49 years, female, white 56.1
TCGA-14-0789-01A 54 years, male, white 54.9
TCGA-06-0878-01A 74 years, male, white 52.8
TCGA-02-0047-01A 78 years, male, white 52.6
TCGA-06-0882-01A 30 years, male, white 51.8
TCGA-12-0619-01A 60 years, male, white 51.5
TCGA-41-4097-01A 63 years, female, white 41.0
Show all

GLIOMA - Protein expressioni

A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.

Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

 

Antibody HPA042775

Antibody HPA048147

 Antibody staining
  High
  Medium
  Low
  Not detected
   
 Intensity
  Strong
  Moderate
  Weak
  Negative
   
 Quantity
  >75%
  75%-25%
  <25%
  Rare
  Negative
   
 Location
  Cytoplasmic/membranous,nuclear
  Cytoplasmic/membranous
  Nuclear
  None
   

Click images for details









































Contact

  • BLOG
  • PRESS ROOM
  • contact@proteinatlas.org

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS
  • DOWNLOADABLE DATA

The Human Protein Atlas

  • ANTIBODY AVAILABILITY
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.